Australia markets closed

Jasper Therapeutics, Inc. (JSPR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.7800+0.0288 (+3.83%)
At close: 04:00PM EDT
0.7790 -0.00 (-0.13%)
After hours: 07:19PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 83.23M
Enterprise value -29.34M
Trailing P/E 0.53
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.75
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.51

Trading information

Stock price history

Beta (5Y monthly) 1.91
52-week change 3-7.28%
S&P500 52-week change 317.24%
52-week high 33.8000
52-week low 30.3860
50-day moving average 31.2587
200-day moving average 31.4502

Share statistics

Avg vol (3-month) 3311.25k
Avg vol (10-day) 3605.78k
Shares outstanding 5110.8M
Implied shares outstanding 6110.8M
Float 857.27M
% held by insiders 17.91%
% held by institutions 187.68%
Shares short (30 Aug 2023) 41.09M
Short ratio (30 Aug 2023) 46.83
Short % of float (30 Aug 2023) 41.10%
Short % of shares outstanding (30 Aug 2023) 40.98%
Shares short (prior month 30 July 2023) 41.01M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 June 2023


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-37.42%
Return on equity (ttm)-65.58%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -57.14M
Net income avi to common (ttm)-55.41M
Diluted EPS (ttm)-0.9500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)115.81M
Total cash per share (mrq)1.04
Total debt (mrq)3.23M
Total debt/equity (mrq)2.93%
Current ratio (mrq)13.22
Book value per share (mrq)1.00

Cash flow statement

Operating cash flow (ttm)-45.9M
Levered free cash flow (ttm)-28.8M